Net Cash Provided by (Used in) Operating Activities |
112M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
1.8B |
USD |
+499% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-2.03B |
USD |
-483% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
175M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
104M |
shares |
+0.49% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-120M |
USD |
-113% |
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
126M |
USD |
-41.7% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.44M |
USD |
-86.6% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
24.9M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
5.95B |
USD |
+0.2% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
24.9M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Share-based Payment Arrangement, Expense |
11.6M |
USD |
+6.42% |
Q2 2025 |
Q2 2025 |
Interest Expense |
562M |
USD |
-14.2% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |